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Background: Hyperlipidemia is one of the most important modifiable risk factors for 
cardiovascular disease (CVD). It is characterized by an elevation of any or all lipid profiles 
and/or lipoproteins in the blood. Oxidative stress has been shown to play a role in 
hyperlipidemia, CVD, infectious diseases, cancer, diabetes, anemia and neurodegenerative 
pathology. Aim: The aim of the study was to evaluate the effect of oral administration of l-
citrulline on lipid peroxidation and some antioxidant enzymes activities on hyperlipidemic 
wistar rats. Methods: The animals were made hyperlipidemic by intraperitoneal injection of 
poloxamer-407. Twenty-five (25) male Wistar rats weighing 100-120g, were grouped into five 
of 5 animals each. Animals in Group I (Normal Control) received distilled water only, while 
animals in Groups II, III, IV and V were given Poloxamer-407 intraperitoneally after every 48 
hours and subsequently Groups III, IV and V were treated orally with Atorvastatin (10mg/kg), 
L-Citrulline (L-Citt) 400 mg and L-Citrulline 800 mg respectively for twenty-one (21) days. 
Results: Malondialdehyde (MDA) concentration an index of lipid peroxidation, decreased in a 
dose dependent manner compared to the HLD only group (35.76±2.32, 35.02 ±2.55) ng/dl vs. 
(41.86±2.19) ng/dl. however, it was not significant(p<0.05). Catalase was significantly (p<0.05) 
decreased from (33.47±3.13) ng/dl to (18.35 ± 2.19) ng/dl. Superoxide dismutase level increased 
from (40.96±3.08) ng/dl to (46.30±1.42, 45.14±1.39) ng/dl however, it was insignificant 
(p<0.05). Reduced glutathione peroxidase recorded no significance. Conclusion: 
Administration of L-citrulline fails to proffer significant decrease in lipid peroxidation and 
increase in antioxidant enzyme SOD.  
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INTRODUCTION   
Hyperlipidemia is a disorder characterized by increase in 
lipoprotein or cholesterol blood levels. It is viewed as the 
primary mediator of a cascade of heart damaging events 
such as renal injury, stroke, atherosclerosis and 
metabolic syndrome (Xu et al., 2007; Baby and 
Anuradha, 2013). 
Poloxamer 407 (Pluronic RF-127) has been used to 
induce hyperlipidemia in rats. P-407 is a biocompatible, 
non-ionic surfactant, considered non-toxic and safe 
during chronic administration for long term studies  
 
 
(Megalli et al., 2005). Oxidative stress as a result of 
hyperlipidemia has been shown to damage the structural 
and functional integrity of the cell either by directly 
modifying cellular DNA, proteins, and membrane lipids 
or by initiating chain reactions that cause extensive 
oxidative damage to DNA, proteins, and membrane 
lipids (Zhao et al., 2014). Oxidative stress also occurs as 
a result of decreased antioxidant defenses and has been 
related to the pathogenesis of atherosclerosis, and 
diabetes mellitus (Fisher-wellman et al., 2009). 
Antioxidants are known to play important roles in 
biological systems by scavenging free radicals which 
may result in oxidative damage of biological molecules 
such as lipids, proteins and DNA. 
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L-Citrulline is a colorless, water soluble α-amino acid 
with an asymmetric carbon. It derives its name from 
watermelon Citrullus lanatus (Eberhardt et al., 2014). It 
is a naturally occurring nonessential amino acid 
endogenous to most living systems (Davis et al., 2011). 
L-Citrulline is the natural precursor of L-arginine, 
substrate for nitric oxide synthase (NOS) in the 
production of nitric oxide (NO) (Maritza et al., 2006). It 
plays an important role in the metabolism and regulation 
of NO (Jabłecka et al., 2012; Suzuki et al., 2016). The 
hallmark of most cardiovascular disorders is NO 
dysfunction. Hence, optimizing eNOS function and 
availability might be helpful in mitigating CVD, making 
L-Citrulline a possible alternative candidate for 
supplementation. 
 
According to the WHO, ischemic heart disease 
attributable to high cholesterol, is the leading cause of 
cardiovascular disease mortality rate globally. Overall, 
raised cholesterol is estimated to cause 2.6 million 
deaths (4.5% of total) and 29.7 million disability 
adjusted life years (DALYs), or 2% of total DALYs. In 
2008, the global prevalence of raised total cholesterol 
among adults (≥5.0 mmol/L) was 39% (37% for males 
and 40% for females (WHO, 2015).  
Therefore, this study was designed to evaluate the effect 
of oral administration of l-citrulline on lipid 
peroxidation (serum malondialdehyde concentration) 
and some antioxidant enzymes (superoxide dismutase 




This study was carried out in the Physiology Laboratory 
of the Department of Human Physiology, Faculty of 
Basic Medical Sciences, College of Health Sciences, 
Ahmadu Bello University Zaria, Kaduna state, Nigeria.  
 
Chemicals and Reagents 
L-Citrulline pure powder (1.5g) of pharmaceutical grade 
was obtained from NOW FOODS, USA. Atorvastatin 
tablets 10 mg, Normal saline, distilled water used for this 
study were purchased from the Pharmacy of the Ahmadu 
Bello University Teaching Hospital (ABUTH) Shika, 
Zaria. All chemicals were commercially obtained and 
were of analytical grade. 
 
Ethical Approval 
The rats were handled in accordance with the principles 
guiding the use and handling of experimental animals of 
Ahmadu Bello University Zaria, Nigeria. 
 
Experimental animals 
(25) Male wistar rats weighing 100-120g were obtained 
from the Animal House of the Department of Human 
Physiology, Ahmadu Bello University Zaria, Nigeria. 
The animals were kept and maintained under laboratory 
condition of ambient temperature, relative humidity and 
12-hour light-dark cycle. They were fed on standard 
commercial feeds with water ad libitum. The animals 
were housed five animals per cage in five groups. 
 
Induction of Experimental Hyperlipidemia 
Hyperlipidemia was induced by single intraperitoneal 
injection of Poloxamer-407 at a dose of   500 mg/kg 
twice a week for 3 weeks (Woo et al., 2010). Poloxamer-
407 (Lutrol F127; BASF, Ludwigshafen, Germany) was 
dissolved in fresh 0.13 g/ml cold normal saline and 
stored in a refrigerator overnight to facilitate its proper 
dissolution. P-407 increases serum lipoproteins via its 
actions at various levels in lipid metabolism, largely by 
inhibiting lipoprotein lipase, which facilitates the 
hydrolysis of triglycerides (TG). 
 
Experimental Protocol and Treatment  
A total of 25 male Wistar rats were used; they were 
randomly divided into five groups of five animals each 
as shown in Table 1.  
 
Table1: Showing the Animal Grouping and 
Experimental Protocol 
 
Groups  Treatment  Sample 
size(n) 
Duration 
I Distilled water 5 21 days 
II P-407 only (500mg/kg) 5 48 hourly 
III P-407+ 
Atorvastatin(10mg/kg) 
5 21 days 
IV P-407+ L-Citrulline 
(400mg/kg) 
5 21 days 
V P-407+ L-Citrulline 
(800mg/kg) 
5 21 days 
 
 
L-Citrulline dose preparation and administration 
The stock concentration was prepared by dissolving 5 g 
of L-Citrulline supplement in 10 ml of distilled water. 
The preparation was administered orally at 400 mg and 
800 mg body weight of rats for twenty-one (21) days. 
 
Sample Collection and Serum Preparation  
At the end of the experiment (21 days) the animals were 
fasted overnight and anaesthetized using ketamine. 
Blood samples was collected from the apex of the rat’s 
heart in all the groups via cardiac puncture technique 
using a 5ml syringe into plain specimen bottles and 
allowed to clot, and separated by centrifugation at 2,000 
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g for 10 minutes using Centrifuge Hettich (Universal 32, 
Made in Germany).  
 
Estimation of Biomarkers of Oxidative Stress and Lipid 
Peroxidation 
Determination of serum superoxidase dismutase 
activity  
Superoxide dismutase (SOD) was determined by the 
method described by Fridovich, (1989). The ability of 
superoxide dismutase (SOD) to inhibit auto oxidation of 
adrenaline at pH 10.2 forms the basis of this assay. 0.1ml 
of Serum was diluted in 0.9ml of distilled water to make 
1:10 dilution of micro some. An aliquot mixture of 0.2ml 
of the diluted microsome was added to 2.5ml of 0.05M 
carbonate buffer. The reaction was started with the 
addition of 0.3ml of 0.3mM Adrenaline.  The reference 
mixture contained 2.5ml of 0.05M carbonate buffer, 
0.3ml of 0.3mM Adrenaline and 0.2ml of distilled water. 
The Absorbance was measured over 30 seconds up to 
150 seconds at 480nm. 
 
Determination of Catalase Activity (CAT) 
Catalase (CAT) activity was measured using Aebi's 
method (1974). Exactly 100µl of serum was added to a 
test tube containing 2.80ml of 50mM potassium 
phosphate buffer (pH 7.0). The reaction was initiated by 
adding 1ml of freshly prepared 30mM H2O2 and the 
decomposition rate of H2O2 was measured at 240nm for 
5 minutes on a spectrophotometer. A molar extinction 
coefficient (E) of 0.041mM¯1 -cm¯1 was used to 
calculate the Catalase activity. Unit: One unit was the 
amount of Catalase that decompose 1µmol of H2O2 per 
min at pH 7.0 
 
Assay of Glutathione Concentration (GSH) 
Reduced glutathione (GSH) concentration measurement 
was done according to Ellman (1959) as described by 
Rajagopalan et al. (2004). It is based on the reaction of 
5,5- dithiobis nitro benzoic acid (DNTB) and reduced 
Glutathione (GSH). To 150µl of serum homogenate (in 
phosphate - saline buffer pH 7.4), 1.5ml of 10% TCA 
was added and centrifuge at 1500g for 5 minutes. 1 ml 
of the supernatant was treated with 0.5ml of Ellman's 
reagent and 3ml of phosphate buffer (0.2M, pH 8.0). The 
absorbance was read at 412nm.The quantity of GSH was 
obtained from the graph of the GSH standard curve. 
 
Assessment of lipid peroxidation (Malondialdehyde 
Concentrations)  
Malondialdehyde (MDA) concentrations is one of the 
many low molecular weight end-products of lipid 
hydroperoxide decomposition and is the most often 
measured as an index of lipid peroxidation. Lipid 
peroxidation is evident by formation of TBARS 
measured by the modified method of Niehaus and 
Samuelson (1968) and described by Akanji et al. (2009). 
150µl of  serum homogenate where treated with 2 ml of 
TBA-TCA-HCL reagent (1:1:1 ratio) and place in a 
water bath at 90ᵒC for 60 minute, the mixture was cooled 
and centrifuged at 3000rpm for 5 minutes and the 
absorbance of the pink supernatant (TBA- 
Malonaldehyde complex was then measured at 535nm. 
Malonaldehyde formed was then calculated using the 
Molar extinction coefficient of 1.56 x 10¯5 cm¯1M¯1 
 
Statistical Analysis 
Data collected was expressed as Mean + SEM. It was 
analyzed by one-way analysis of variance, ANOVA, and 
Tukey’s post-hoc test was used to compare the level of 
significance between the controls and treatment groups, 




Effect of L-Citrulline on Superoxide Dismutase Activity 
in Hyperlipidemia Induced Male Wistar Rats 
Figure 1 Shows the effects of treatment on superoxide 
dismutase. Superoxide dismutase was lower in the HLD 
only group compared to the normal control (40.96±3.08 
ng/dl vs 53.40±2.59 ng/dl) respectively. SOD in the 400 
mg/dl L-Citt and 800 mg/dl L-Citt group was 
insignificantly higher compared to the HLD only group 
with a value of (46.30±1.42 ng/dl, 45.14±1.39 ng/dl vs 
40.96±3.08 ng/dl respectively). 
 
 
Fig. 1: Effect of L-Citrulline on superoxide dismutase activity in 
hyperlipidemia induced male Wistar rats. Values with different 
superscript are statistically significant (p˂0.05). superscript 
a,b,c  indicate statistical  significant compared to control. HLD= 
hyperlipidemia, ATR= atorvastatin, L-CITT=L-Citrulline 
 
L-Citrulline effects in Hyperlipidemic Wistar Rats 
 
37   J. Afr. Ass. Physiol. Sci. 8 (1): 2020                                                    Ajibade et al 
 
 
Effect of L-Citrulline on Serum Catalase Activity 
Hyperlipidemia Induced Male Wistar Rats 
Figure 2 shows the effects of treatment on catalase. 
Catalase increased in the HLD only group when 
compared with the normal control group (33.47±3.13 
ng/dl vs 10.31±0.64 ng/dl) respectively. Catalase was 
significantly decreased in the 400 mg L-Citt as 
compared to the HLD only group (18.35 ± 2.19 ng/dl vs 
33.47±3.13 ng/dl) respectively.  Catalase was 
significantly increased (p<0.05) in the 800 mg L-Citt 
group as compared to the 400 mg L-Citt. Group 
(30.67±1.03 ng/dl vs 18.35 ± 2.19 ng/dl respectively). 
 
Fig. 2. Effect of L-Citrulline on catalase in hyperlipidemia induced 
male Wistar rats. Values with different superscript are statistically 
significant (p˂0.05). Superscript a,b,c indicate statistical significant 
compared to control, HLD only and HLD+ 400 mg/kg L-Citt. 
HLD= hyperlipidemia, ATR= atorvastatin, L-CITT=L-Citrulline 
 
Effect of L-Citrulline on Reduced Glutathione Activity 
in Hyperlipidemia Induced Male Wistar Rats 
Figure 3 shows the effects of treatment on reduced 
glutathione peroxidase. Reduced glutathione peroxidase 
was insignificantly lower in HLD only group as 
compared to the normal control group (15.40±0.65 ng/dl 
vs 18.24±1.49 ng/dl respectively).  The 400 mg L-Citt 
and 800 mg L-Citt group showed no significant 
difference compared to the HLD only group (15.14±0.55 
ng/dl, 14.36±0.48 ng/dl vs 15.4±0.65 ng/dl 
respectively). 
 
Effects of L-Citrulline on Malondialdehyde In 
Hyperlipidemic male Wistar Rats 
Figure 4 Shows the effects of treatment on 
Malondialdehyde. Malondialdehyde was significantly 
higher in HLD only, HLD+ATR, 400mg L-Citt and 
800mg L-Citt group compared to the normal control 
group (41.86±2.19 ng/dl, 35.76±2.03 ng/dl, 35.76±2.32 
ng/dl, 35.02 ±2.55 ng/dl vs 25.06±1.81 ng/dl). MDA 
levels in the 400mg L-Citt and 800mg L-Citt group 
showed a slight but insignificant decrease compared to 
the HLD only group (35.76±2.32 ng/dl, 35.02 ±2.55 
ng/dl vs 41.86±2.19 ng/dl). 
 
 
Fig. 3: Effect of L-Citrulline on reduced glutathione in 
hyperlipidemia induced male Wistar rats. Values with 
different superscript are statistically significant (p˂0.05). 
HLD= hyperlipidemia, ATR= atorvastatin, L-CITT=L-
Citrulline 
Fig. 4: Effect of L-Citrulline on Malondialdehyde (MDA) in 
hyperlipidemia induced male Wistar rats. Values with 
different superscript are statistically significant (p˂0.05). 
Superscript a indicate statistically significant compared to 




This study investigated the antioxidant activity of L-
Citrulline in hyperlipidemic Wistar rats. The 
experimental model used was Poloxamer-407 (P-407) to 
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induce hyperlipidemic in rat model. Oxidative stress 
occurs when the effect of reactive oxygen (ROS) and 
reactive nitrogen (RNS) species overcomes the 
physiological antioxidant defense mechanisms (Luciano 
and Omidreza, 2014). The health-related applications of 
oral L-citrulline supplementation are largely predicated 
on the capacity for L-citrulline to increase L-arginine 
availability for NO production (Luciano and Omidreza, 
2014). 
Superoxide dismutase level (SOD) is known to offers the 
first line of antioxidant defense. From the result obtained 
in our study, (SOD) was lowered in p-407 only group, 
compared to the control and treatment groups which 
could probably be due to the increase in the ROS level 
of the p-407 only group and the used-up of the SOD in 
doing the oxidation to prevent ROS formation. L-
Citrulline antioxidant effect has been thought to work by 
probably decreasing reactive oxygen species (ROS), 
thus preventing (ROS) mediated damage and also 
increasing NO bioavailability. However, increase in 
SOD in the L-Citrulline treated groups could be as a 
result of ROS reacting with NO at a higher rate than 
SOD to form peroxynitrite, thereby improving NO 
bioavailability and SOD activity concomitantly. That is 
l-citrulline upregulating SOD to do the oxidation. 
Previous research reported that Dietary antioxidant 
could initiate antioxidant defense to combat excessive 
ROS production. This was done either by direct 
scavenging of hydroxyl radicals to form water or 
inhibition of hydroxyl radical production (Coles, 2007). 
This agrees with the work of Victoria et al., (2020) who 
worked on dietary l-citrulline supplementation in hens 
and recorded an increase in enzymatic activity of serum 
SOD in heat stressed hen. Santos and Jennifer, (2016), 
also demonstrated an increased in serum SOD level in 
endothelial cells arterial dysfunction. 
Ankita et al. (2019), describes catalase as a key regulator 
of ROS. it decomposes hydrogen peroxide to 
insignificant products such as water and oxygen. Serum 
Catalase level was increased significantly in the P-407 
group only. An increase in serum catalase activity in the 
P-407 group could be due to an upregulation of the 
inherent antioxidant enzymes to abate the effect of 
oxidative stress. Moldogazieva et al. (2018), in their 
findings revealed that appropriate intracellular levels of 
ROS play a crucial role in physiological redox signaling 
via activation and regulation of endogenous defenses by 
protecting cells from oxidative stress damage. 800 
mg/kg l-Citrulline had an increased catalase level 
compared to 400 mg /kg of l-Citrulline. This might 
probably be a synergetic act of upregulating the 
antioxidant system through the NO pathway. 
Antioxidants can act either as direct scavengers of 
superoxide or as blockers of the primary superoxide 
formation. Poor aqueous solubility and low stability 
limits the therapeutic potentials of antioxidants, which 
limit antioxidant bioavailability (Tan et al., 2018). 
 
 Serum MDA concentrations level is often considered as 
an index of free radical generation which increases in 
conditions of oxidative stress (Kehrer, 1993). Disorders 
of lipid metabolism such as hyperlipidemia, results in 
modification of cellular reaction that produces ROS. 
Oxidative stress results from over production of ROS, 
failure of host antioxidant defense or both (Fostermann, 
2006). Increase in serum MDA concentrations 
demonstrated lipid peroxidation in P-407 group, 
compared to the normal control group. L-citrulline 
treated groups had a non-significant decline in serum 
MDA concentrations, demonstrating its possible 
ameliorative effect on lipid peroxidation and also 
stabilization of the cell membrane. This implies that 
oxidative stress was countered probably due to the up-
regulation of the NO pathway. Elevations in reactive 
oxygen species (ROS), especially superoxide (O2−), can 
reduce the bioavailability of NO through the generation 
of peroxynitrite (ONOO−). Atorvastatin a standard drug 
is known to decreased lipid peroxidation; however, it 
was non-significant in our study. Several studies (Jones 
et al., 2003; Jukema et al., 2004), recorded that low dose 
atorvastatin was less efficacious in reducing lipid 
peroxidation. Hence, this could be likened to the dosage 
of the atorvastatin used in the study.  Reduced 
glutathione had no significant difference across the 
group; however, it was reduced in the P-407group. 
 
CONCLUSION 
P-407 induced hyperlipidemia and causes oxidative 
damage by lowering the antioxidant enzyme activity. L-
Citrulline alone is not enough to ameliorate some 
conditions associated with oxidative stress in 
hyperlipidemia. We suggest that more studies should be 
carried out on the long-term effect of l-citrulline and its 
action with other drugs or supplements. 
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